Internal Medicine · San Francisco, CA
NPI
1609990993
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
4
Hospital affiliations
2480 Mission St, Suite 108
San Francisco, CA, 94110
Phone (415) 642-2000
Medicare paid, 2024
$159K
2,613 services
Medicare patients, 2024
196
Average age 72
Drug cost, 2024
$5.8M
6,695 prescriptions
Company payments, 2025
$4,913
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lee R Liskey was code 99212 (office e&m - established), 1,580 times for 181 patients. In total Lee R Liskey billed 2,613 services in 12 codes, and Medicare paid $159K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99212 Office E&M - Established | Office | 1,580 | 181 | $40.02 | $63K |
| 99214 Office E&M - Established | Office | 517 | 119 | $93.42 | $48K |
| 17004 Destruction Skin Lesion | Office | 173 | 54 | $160.31 | $28K |
| 99215 Office E&M - Established | Office | 146 | 97 | $111.34 | $16K |
By year: 2022 $140K for 2,588 services; 2023 $151K for 2,677 services; 2024 $159K for 2,613 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lee R Liskey prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 238 prescriptions and refills. In total Lee R Liskey wrote 6,695 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 238 | 242 | 24 | $971K |
| Gabapentin Generic | 155 | 206 | 25 | $2,249 |
| Atorvastatin Calcium Generic | 155 | 351 | 38 | $1,146 |
| Acyclovir Generic | 144 | 170 | 19 | $4,173 |
| Oxycodone Hcl Generic | 142 | 142 | 12 | $2,170 |
| Lisinopril Generic | 122 | 215 | 20 | $499 |
| Zolpidem Tartrate Generic | 117 | 127 | 16 | $802 |
| Tamsulosin Hcl Generic | 114 | 213 | 23 | $1,647 |
| Testosterone Generic | 113 | 117 | 22 | $14K |
| Finasteride Generic | 112 | 153 | 18 | $713 |
| Lorazepam Generic | 108 | 110 | 19 | $416 |
| Trazodone Hcl Generic | 107 | 142 | 17 | $694 |
| Clonazepam Generic | 103 | 103 | 12 | $302 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 102 | 102 | 14 | $1,337 |
| Testosterone Cypionate Generic | 100 | 153 | 24 | $4,596 |
Brand drugs: 1,857 claims; generic drugs: 4,813 claims; opioid claims: 384.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lee R Liskey $4,913 ($4,913 in general payments such as food, travel and fees) from 21 companies. The largest payer was ViiV Healthcare Company with $1,460.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 59 | $1,460 |
| Gilead Sciences, Inc. GILD | 30 | $747 |
| EMD Serono, Inc. MRK.DE | 28 | $557 |
| Abbvie Inc. ABBV | 18 | $404 |
| Merck Sharp & Dohme LLC MRK | 11 | $290 |
| Antares Pharma, Inc. | 11 | $258 |
| Theratechnologies Inc. THTX | 12 | $234 |
| Aimmune Therapeutics, Inc. | 6 | $158 |
| Bausch Health US, LLC BHC | 8 | $144 |
| Lilly USA, LLC LLY | 5 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.